Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
48
NCT01003808
Safety Study of a Recombinant Protein Vaccine to Treat Esophageal Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 30, 2009
Completion: Dec 31, 2012
NCT01234012
Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1
Start: May 31, 2011
Completion: Mar 31, 2014